In a meta-analysis of 19 studies, investigators compared the effects of metabolic surgery vs medical therapy on mortality and the incidence of microvascular complications in type 2 diabetes. The findings...
In type 2 diabetes, empagliflozin (EMPA) likely has beneficial renal effects regardless of patients’ level of glycemic control prior to and during therapy, according to ne
In patients with type 2 diabetes, long-term decreases in estimated glomerular filtration rate (eGFR) and increases in urine albumin-to-creatinine ratio (UACR) are associat
The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have released an updated consensus statement on the management of hyperglycemia in patients with type 2...
Because of the relationship between bodyweight and the risk of diabetes, researchers sought to examine the long-term effects of a selective serotonin 2C receptor agonist and appetite-suppressant drug which...
In a recent study, researchers sought to evaluate the impact of treatment with a glucagon-like peptide 1 receptor agonist on rates of cardiovascular events in patients with type 2 diabetes and...
As treatment of type 1 diabetes continues to improve, more patients with the condition are expected to survive to adulthood, according to the researchers. For this reason, they sought to examine the...
Javier Morales, MD, offered a review of glucagon-like peptide-1 receptor agonists and how they fit into the management of patients with type 2 diabetes.
